Peer-reviewedCC BYMedComm
Baricitinib as Salvage Therapy for Multidrug-Resistant Chronic Graft-Versus-Host Disease.
- 1Peking University People's Hospital Peking University Institute of Hematology National Clinical Research Center for Hematologic Disease Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies Peking University Beijing China.
Related
- Therapeutic Plasma Exchange as Salvage Therapy in Paediatric Fulminant Hepatitis A Complicated by Acute Kidney Injury and Multidrug-Resistant Pneumonia: A Case Report
- Nursing care of a child with cerebral palsy and multidrug-resistant bacterial pneumonia treated with bacteriophage therapy: a case report
- Case Report: Low-dose radiotherapy as part of multimodal salvage therapy for immunotherapy-resistant SMARCA4-deficient non-small cell lung cancer.
- Early best available antibiotic therapy for multidrug-resistant gram-negative bloodstream infections: a target trial emulation
- Temporal proximity to counseling is associated with longitudinal bedaquiline and antiretroviral therapy adherence in multidrug-resistant tuberculosis and HIV treatment
BibTeX
@article{an2026baricitinib,
title = {{Baricitinib as Salvage Therapy for Multidrug-Resistant Chronic Graft-Versus-Host Disease.}},
author = {Zhuo-Yu An and Chen Zhao and Yuanyuan Zhang and Xiaodong Mo and Leqing Cao and Daoxing Deng and Jun Kong and Fengrong Wang and Xiaojun Huang and Xiaohui Zhang},
journal = {MedComm},
year = {2026},
month = oct,
doi = {10.1002/mco2.71094},
url = {https://europepmc.org/article/MED/42948231},
note = {CC BY},
}
RIS
TY - JOUR
TI - Baricitinib as Salvage Therapy for Multidrug-Resistant Chronic Graft-Versus-Host Disease.
AU - Zhuo-Yu An
AU - Chen Zhao
AU - Yuanyuan Zhang
AU - Xiaodong Mo
AU - Leqing Cao
AU - Daoxing Deng
AU - Jun Kong
AU - Fengrong Wang
AU - Xiaojun Huang
AU - Xiaohui Zhang
PY - 2026
DA - 2026/10/27
JO - MedComm
DO - 10.1002/mco2.71094
UR - https://europepmc.org/article/MED/42948231
SN - 2688-2663
ER -